SYRE
Spyre Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Spyre Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Spyre Therapeutics, Inc.
99.08
−0.19 · −0.19%
post 99.11 +0.03%
6 direct
Expected move
Inputsspot 100.10exp Mar 19ATM strike 100ATM straddle 30.10IV 63%